BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37563671)

  • 21. GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile.
    Chaudhari N; Dawalbhakta M; Nampoothiri L
    Reprod Biol Endocrinol; 2018 Apr; 16(1):37. PubMed ID: 29642911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome.
    Hill LD; Ewens KG; Maher BS; York TP; Legro RS; Dunaif A; Strauss JF
    Mol Cell Endocrinol; 2012 Mar; 350(1):72-7. PubMed ID: 22178088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential association of DENND1A genetic variants with polycystic ovary syndrome in Tunisian but not Bahraini Arab women.
    Dallel M; Sarray S; Douma Z; Hachani F; Al-Ansari AK; Letaifa DB; Mahjoub T; Almawi WY
    Gene; 2018 Mar; 647():79-84. PubMed ID: 29325736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.
    Almawi WY; Hubail B; Arekat DZ; Al-Farsi SM; Al-Kindi SK; Arekat MR; Mahmood N; Madan S
    J Assist Reprod Genet; 2015 Apr; 32(4):607-14. PubMed ID: 25649397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
    Valkenburg O; Uitterlinden AG; Piersma D; Hofman A; Themmen AP; de Jong FH; Fauser BC; Laven JS
    Hum Reprod; 2009 Aug; 24(8):2014-22. PubMed ID: 19403562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovary syndrome (PCOS) and kisspeptin - A Sri Lankan study.
    Umayal B; Jayakody SN; Chandrasekharan NV; Wijesundera WS; Wijeyaratne CN
    J Postgrad Med; 2019; 65(1):18-23. PubMed ID: 30004037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.
    Day F; Karaderi T; Jones MR; Meun C; He C; Drong A; Kraft P; Lin N; Huang H; Broer L; Magi R; Saxena R; Laisk T; Urbanek M; Hayes MG; Thorleifsson G; Fernandez-Tajes J; Mahajan A; Mullin BH; Stuckey BGA; Spector TD; Wilson SG; Goodarzi MO; Davis L; Obermayer-Pietsch B; Uitterlinden AG; Anttila V; Neale BM; Jarvelin MR; Fauser B; Kowalska I; Visser JA; Andersen M; Ong K; Stener-Victorin E; Ehrmann D; Legro RS; Salumets A; McCarthy MI; Morin-Papunen L; Thorsteinsdottir U; Stefansson K; ; Styrkarsdottir U; Perry JRB; Dunaif A; Laven J; Franks S; Lindgren CM; Welt CK
    PLoS Genet; 2018 Dec; 14(12):e1007813. PubMed ID: 30566500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.
    Miura I; Zhang JP; Hagi K; Lencz T; Kane JM; Yabe H; Malhotra AK; Correll CU
    Psychoneuroendocrinology; 2016 Oct; 72():1-10. PubMed ID: 27333159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal expression of G-protein-coupled receptor 54 (GPR54), gonadotropin-releasing hormones (GnRH), and dopamine receptor D2 (drd2) in pubertal female grey mullet, Mugil cephalus.
    Nocillado JN; Levavi-Sivan B; Carrick F; Elizur A
    Gen Comp Endocrinol; 2007 Jan; 150(2):278-87. PubMed ID: 17083940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphic variants in the dopamine receptor D2 in women with endometriosis-related infertility.
    Szczepańska M; Mostowska A; Wirstlein P; Skrzypczak J; Misztal M; Jagodziński PP
    Mol Med Rep; 2015 Aug; 12(2):3055-60. PubMed ID: 25955176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.
    Saxena R; Welt CK
    Acta Diabetol; 2013 Jun; 50(3):451-7. PubMed ID: 22389004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FSH receptor gene p. Thr307Ala and p. Asn680Ser polymorphisms are associated with the risk of polycystic ovary syndrome.
    Kim JJ; Choi YM; Hong MA; Chae SJ; Hwang K; Yoon SH; Ku SY; Suh CS; Kim SH
    J Assist Reprod Genet; 2017 Aug; 34(8):1087-1093. PubMed ID: 28547204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome.
    Ewens KG; Jones MR; Ankener W; Stewart DR; Urbanek M; Dunaif A; Legro RS; Chua A; Azziz R; Spielman RS; Goodarzi MO; Strauss JF
    Fertil Steril; 2011 Jun; 95(8):2538-41.e1-6. PubMed ID: 21444075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome.
    Kahsar-Miller M; Boots LR; Azziz R
    Fertil Steril; 1999 Mar; 71(3):436-8. PubMed ID: 10065778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.
    Waterworth DM; Bennett ST; Gharani N; McCarthy MI; Hague S; Batty S; Conway GS; White D; Todd JA; Franks S; Williamson R
    Lancet; 1997 Apr; 349(9057):986-90. PubMed ID: 9100625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
    Biyasheva A; Legro RS; Dunaif A; Urbanek M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2617-25. PubMed ID: 19351735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.
    Xu G; Zhao X; Li Z; Hu J; Li X; Li J; Chen Y
    J Ovarian Res; 2023 Jan; 16(1):15. PubMed ID: 36650561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS.
    Barber TM; Bennett AJ; Groves CJ; Sovio U; Ruokonen A; Martikainen H; Pouta A; Hartikainen AL; Elliott P; Wass JA; Järvelin MR; Zeggini E; Franks S; McCarthy MI
    Diabetologia; 2007 Nov; 50(11):2318-22. PubMed ID: 17805508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.